Unknown

Dataset Information

0

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant.


ABSTRACT: We developed a SARS-CoV-2 spike subunit vaccine formulation containing dual TLR ligand liposome adjuvant. The vaccine-induced robust systemic neutralizing antibodies and completely protected mice from a lethal challenge. Two immunizations protected against lung injury and cleared the virus from lungs upon challenge. The adjuvanted vaccine also elicited systemic and local anti-Spike IgA which can be an important feature for a COVID-19 vaccine.

SUBMITTER: Abhyankar MM 

PROVIDER: S-EPMC8602664 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6219601 | biostudies-other
2022-10-14 | PXD031969 | Pride
| S-SCDT-EMM-2021-15227 | biostudies-other
2023-01-12 | GSE199750 | GEO
| S-EPMC5227169 | biostudies-literature
| S-EPMC7785583 | biostudies-literature
| S-EPMC6381837 | biostudies-literature
| S-EPMC7767004 | biostudies-literature
| S-EPMC8437828 | biostudies-literature
| S-EPMC8590511 | biostudies-literature